Table 3. QCA analysis.

			Genoss DES™ (n=38)	Promus Element™ (n=39)	p
RVD (mm)
		Pre-procedure	3.24±0.41	3.12±0.43	0.199
		Post-procedure	3.30±0.30	3.33±0.30	0.652
		9-month follow-up	3.17±0.35	3.16±0.39	0.932
Minimal lumen diameter (mm)
	In-stent
		Pre-procedure	NA	NA	NA
		Post-procedure	2.95±0.35	3.03±0.30	0.269
		9-month follow-up	2.84±0.42	2.87±0.56	0.743
	In-segment
		Pre-procedure	0.83±0.29	0.88±0.45	0.572
		Post-procedure	2.90±0.27	3.00±0.36	0.159
		9-month follow-up	2.79±0.40	2.85±0.56	0.615
DS %
	In-stent
		Pre-procedure	NA	NA	NA
		Post-procedure	10.6±3.48	9.16±4.85	0.140
		9-month follow-up	14.18±9.31	13.73±14.30	0.871
	In-segment
		Pre-procedure	74.41±8.62	72.65±12.14	0.465
		Post-procedure	12.10±3.93	10.12±4.94	0.056
		9-month follow-up	15.46±9.39	14.54±14.08	0.738
Acute gain (mm)
	In-stent		1.79±0.40	1.82±0.36	0.742
	In-segment		1.74±0.39	1.78±0.38	0.579
Late loss (mm)
	In-stent		0.11±0.25	0.16±0.43	0.567
	In-segment		0.11±0.26	0.15±0.43	0.558
Lesion length (mm)			23.8±8.1	22.8±4.9	0.531
Restenosis			1 (2.6)	2 (5.1)	1.000

Data are shown as mean±standard deviation or number (%).

DES = drug-eluting stent; DS = diameter stenosis; NA = not available; QCA = quantitative coronary angiography; RVD = reference vessel diameter.